IRIS
PARISI, GIUSEPPE FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.396
AS - Asia 1.366
EU - Europa 864
SA - Sud America 233
AF - Africa 202
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.065
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.326
SG - Singapore 627
CN - Cina 464
IT - Italia 318
BR - Brasile 196
IE - Irlanda 191
CI - Costa d'Avorio 147
KR - Corea 85
DE - Germania 71
UA - Ucraina 49
RU - Federazione Russa 48
CA - Canada 47
VN - Vietnam 47
GB - Regno Unito 44
IN - India 37
NL - Olanda 35
SN - Senegal 25
FI - Finlandia 22
HK - Hong Kong 20
PL - Polonia 18
JP - Giappone 17
MX - Messico 16
CZ - Repubblica Ceca 15
NG - Nigeria 14
AR - Argentina 13
BD - Bangladesh 13
SE - Svezia 13
ZA - Sudafrica 10
FR - Francia 9
ID - Indonesia 9
CH - Svizzera 8
ES - Italia 8
IQ - Iraq 8
TR - Turchia 8
PE - Perù 6
CO - Colombia 5
EC - Ecuador 5
PY - Paraguay 5
IR - Iran 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AZ - Azerbaigian 3
BE - Belgio 3
GR - Grecia 3
IL - Israele 3
KG - Kirghizistan 3
MA - Marocco 3
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
HN - Honduras 2
LB - Libano 2
LT - Lituania 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NR - Nauru 1
OM - Oman 1
PK - Pakistan 1
SV - El Salvador 1
TG - Togo 1
TN - Tunisia 1
VE - Venezuela 1
Totale 5.065
Salva come PNG Salva come JPEG
Città #
Santa Clara 471
Dallas 416
Singapore 364
Dublin 191
Chandler 179
Hefei 170
Ashburn 151
Abidjan 147
Los Angeles 113
Chicago 106
Seoul 84
Beijing 76
Boardman 69
Civitanova Marche 65
Cambridge 50
Jacksonville 50
Lawrence 50
Catania 44
New York 43
Andover 38
Nanjing 28
Bremen 26
Amsterdam 25
Dakar 25
Des Moines 24
São Paulo 21
Hong Kong 19
Toronto 18
Lappeenranta 17
Milan 17
Saint Petersburg 17
Tokyo 17
Warsaw 16
Wilmington 15
Abuja 14
Brooklyn 14
Ho Chi Minh City 14
Brno 13
Denver 13
Hanoi 13
Rome 13
Chennai 12
San Francisco 12
Stockholm 12
Council Bluffs 11
Washington 11
Houston 10
Poplar 10
Nanchang 9
Orem 9
Atlanta 7
Manchester 7
Mexico City 7
Montreal 7
Phoenix 7
Ankara 6
Buffalo 6
Frankfurt am Main 6
Johannesburg 6
Redwood City 6
Rio de Janeiro 6
Shenyang 6
Arequipa 5
Calgary 5
Genoa 5
Hebei 5
Messina 5
Mumbai 5
Munich 5
Palermo 5
Redondo Beach 5
San Mateo 5
Tianjin 5
Turin 5
Turku 5
Baghdad 4
Bernareggio 4
Changsha 4
Columbus 4
Dhaka 4
Dong Ket 4
London 4
Misterbianco 4
Pune 4
Tehran 4
The Dalles 4
Bari 3
Bishkek 3
Brussels 3
Charlotte 3
Curitiba 3
Da Nang 3
Falls Church 3
Favara 3
Goiânia 3
Guangzhou 3
Jaraguá do Sul 3
Jiaxing 3
Manaus 3
Mascalucia 3
Totale 3.580
Salva come PNG Salva come JPEG
Nome #
General anesthesia, conscious sedation, or nothing: Decision-making by children during painful procedures 94
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre 90
YKL-40 as marker of severe lung disease in cystic fibrosis patients. 90
The Role of Ultrasound in the Diagnosis of Pulmonary Infection Caused by Intracellular, Fungal Pathogens and Mycobacteria: A Systematic Review 87
Lung clearance index: A new measure of late lung complications of cancer therapy in children 87
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review 87
Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease 86
Minor pulmonary malformations in a child 85
Serum YKL-40 in children with asthma 84
SAFETY AND EFFICACY OF SUBLINGUAL SPECIFIC IMMUNOTHERAPY TO HOUSE DUST MITE USING A DIFFERENT DOSAGE: A PILOT STUDY. 84
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study 83
Proposal for a new therapeutic high dosage of Pidotimod in children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome: A randomized controlled study 83
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility 81
Biomarkers in pediatric lung diseases including cystic fibrosis 81
Lactoferrin: Cytokine modulation and application in clinical practice 81
Hypertransaminasemia in children is not always as simple as it seems 80
Monoclonal antibodies in treating food allergy: A new therapeutic horizon 79
Cetirizine use in childhood: An update of a friendly 30-year drug 78
LUNG CLEARANCE INDEX: a new biomarker of ventilation inhomogeneity in pediatric respiratory diseases. 77
Pilot study shows right ventricular diastolic function impairment in young children with obstructive respiratory disease 77
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis 76
HMGB1 as a new biomarker of celiac disease in children: a multicenter study 76
Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature 76
Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review 75
Exhaled breath temperature in astmatic children 73
Focus on pleiotropic role of HMGB1 in the onset of allergic and non- allergic respiratory diseases 72
HMGB1 values and response to HBV vaccine in children with celiac disease 72
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic 70
Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: A pilot study 70
Antihistamines: ABC for the pediatricians 70
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial 69
Liver disease in Cystic Fibrosis: an update 69
Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool 69
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis 67
Severe Kawasaki disease in a 3-month-old patient: a case report. 66
Novel therapeutic targets for allergic airway disease in children 66
Severe disease in Cystic Fibrosis and fecal calprotectin levels 65
Antihistamines in children and adolescents: A practical update 65
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease 63
Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype 63
Genetic disorders of surfactant deficiency and neonatal lung disease 63
High mobility Group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate - severe asthma 61
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: A pilot study on short-term efficacy 61
Fungi and non-tuberculous mycobacteria: emerging pathogens in cystic fibrosis 60
Cystic Fibrosis: Fighting Together Against Coronavirus Infection 60
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series 59
Lung clearance index for evaluation of late complications of cancer therapy in children 57
Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination 57
Focus on gastroesophageal reflux disease in patients with cystic fibrosis 56
Gastroesophageal reflux and respiratory diseases: Does a real link exist? 56
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study 55
Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study 54
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review 54
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 54
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis 54
Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: a pilot study 53
Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients 53
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria 52
The immunomodulatory role of vitamin D in respiratory diseases 52
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 52
Lower airway microbiota 52
Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer 51
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease 49
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study 49
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population 49
Upper and lower airways diseases in childhood 49
Type 2 inflammation in cystic fibrosis: New insights 48
Cystic Fibrosis and Oxidative Stress: The Role of CFTR 44
Protracted bacterial bronchitis: more to know 44
Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children? 44
Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheat 44
Long-term effects of bronchopulmonary dysplasia on lung function: a pilot study in preschool children’s cohort 44
Impact of COVID-19 on the management of patients with Lysosomal Storage Disorders 42
Nasal microbiome in chronic rhinosinusitis 41
The role of skin infections in atopic dermatitis in children 37
Fish Oil Containing Pro-Resolving Mediators Enhances the Antioxidant System and Ameliorates LPS-Induced Inflammation in Human Bronchial Epithelial Cells 37
Foreign Body Aspiration in Children: Retrospective Case Series and Literature Update 36
Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia 32
Pidotimod in allergic diseases 30
Cutting-Edge Advances in Cystic Fibrosis: From Gene Therapy to Personalized Medicine and Holistic Management 20
Reply to Schriever et al. 15
Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS/CFSPID subjects: A systematic review 14
Oral immunotherapy in children with allergic diseases: past, present and future 14
Observational study of sleep-related breathing disorders and preventive non-invasive ventilation in cystic fibrosis 11
HMGB1 as a Biomarker of Inhaled Corticosteroid Treatment Response in Moderate-Severe Asthmatic Children: A Single Center Pilot Study 10
Evolving Cystic Fibrosis Care: Lung Immunology and Emerging Health Challenges in the Era of CFTR Modulators 9
Efficacy of sublingual allergen-specific immunotherapy in children evaluated by the measurements of bronchial and nasal nitric oxide. Preliminary results 8
Calprotectin in cystic fibrosis: A new marker of flogosis 7
Novel biologics for the treatment of pediatric severe asthma 6
Extreme hyperferritinemia in the pediatric emergency setting: haemophagocytic lymphohistiocytosis, macrophage activation syndrome, sepsis and more 6
Severe Asthma and Active SARS-CoV-2 Infection: Insights into Biologics 6
Real-world effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis patients with Phe508del -gating and -residual function genotypes 5
COVID-19, anosmia, and ageusia in atopic children 5
Correlation between RINT values and echocardiographic indices in pre-school children with chronic cough and wheezing 5
Effectiveness of omalizumab in two children with severe vernal keratoconjunctivitis 4
Zooming in on the ERS fellowships and the international congress 4
Fever and tick-borne disease 4
Plasmatic Amino Acids in Patients with Cystic Fibrosis: An Observational Study 4
Three Consecutive Cases of Double Aortic Arch with Various Clinical Onset 4
Lobar Emphysema in a 7-year-old girl: Acquired Form or Late Onset Congenital Form? 4
Totale 5.176
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021117 0 0 0 0 39 20 18 2 6 15 10 7
2021/2022295 17 42 1 3 43 2 39 10 26 3 7 102
2022/2023656 50 12 36 42 55 109 4 120 160 6 35 27
2023/2024394 15 39 30 25 26 114 3 31 0 1 67 43
2024/20251.625 47 188 68 112 292 310 48 33 75 148 163 141
2025/20261.950 265 330 595 366 394 0 0 0 0 0 0 0
Totale 5.236